Dr Jianmin ChenLecturer in Inflammation and Cardiovascular MedicineCentre: Biochemical PharmacologyEmail: jianmin.chen@qmul.ac.ukProfileResearchPublicationsSponsorsCollaboratorsNewsTeachingDisclosuresProfileDr Jianmin Chen is a Lecturer in Inflammation and Cardiovascular Medicine and Versus Arthritis Career Development Fellow at the William Harvey Research Institute, Queen Mary University of London. Jianmin attained a Doctor’s degree in Clinical Medicine from Sichuan University, China in 2012. She was awarded with a PhD scholarship for her doctoral studies in Cardiovascular Pharmacology at Queen Mary University of London from 2012 to 2016, focusing on pathophysiology and experimental treatments of sepsis-induced cardiac dysfunction. She joined Professor Mauro Perretti’s group at the William Harvey Research Institute as a postdoctoral researcher in 2017. She applies her expertise of cardiovascular research to the fields of arthritis to investigate cardiac comorbidities faced by patients with rheumatoid arthritis. In 2022 she received her Versus Arthritis UK Career Development Fellowship. Her current research aims to investigate the mechanisms for cardiomyopathy in inflammatory arthritis and explore novel therapeutic strategies. Awards and Honours Bülbring Award, British Pharmacology Society Career Development Fellowship, Versus Arthritis UK European New Investigator, European Shock Society WHRI New Investigator Award, William Harvey Research Institute William Harvey Medal & Best Oral Presentation, William Harvey Research Institute New Year Celebration Travel Awards, conferred by Thirty-Eighth Annual Conference on Shock, 16th Congress of the European Shock Society and International Federation of Shock Congress, respectively Links to my other profiles Research Gate LinkedIn Loop ResearchGroup members Mr Ahmad Hjiej Andaloussi (PhD student) Mr Weifeng Bu (PhD student) Mr Thomas Dudley Wright (PhD student, 2nd Supervisor) Dr Marilena Christoforou (Post-doctoral Fellow; PI) Summary Cardiovascular comorbidities contribute to around half of all deaths in patients with rheumatoid arthritis (RA), with non-ischaemic heart failure being a major cause. RA patients are particularly susceptible to a type of heart failure with preserved ejection fraction (HFpEF), which is accompanied by diastolic dysfunction. The causes of diastolic dysfunction in RA are unknown and current medications for RA have limited cardioprotective effects: the clinical unmet need for increased congestive heart failure (CHF) remains pressing. To address this unmet clinical need, we have identified a mouse model of arthritis, K/BxN F1 progeny, which recapitulates the specific diastolic dysfunction of RA patients; this is the first mouse model of inflammatory arthritis identified which shows diastolic dysfunction. My research aims are to understand the pathophysiology of cardiac diastolic dysfunction in inflammatory arthritis and to develop novel therapeutics for this fatal side-effect of arthritis. Ongoing projects include: Identify whether cellular/molecular dysregulation contributes to the development of cardiac dysfunction by analysing immune cell infiltration, and changes in cardiac metabolism in mice with inflammatory arthritis. Test the impact of both established classical anti-inflammatory and innovative pro-resolving therapeutic strategies on cardiac function and joint symptoms in mice with inflammatory arthritis. Assess the translational potential of current research using samples and data obtained from RA patients. Furthermore, I have expertise in modelling a range of both acute and chronic cardiovascular diseases in mice and rats, including inducing polymicrobial sepsis/sepsis-associated cardiac dysfunction by cecum ligation and perforation surgery in mice, haemorrhage shock in rats, myocardial ischemia/reperfusion injury and heart failure in rats. I am also interested in studying the pathophysiology and exploring novel therapeutic treatments of these disease conditions.Publications Chen J, Oggero S, Cecconello C et al. (2023). The Annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation. nameOfConference DOI: 10.1016/j.phrs.2023.107005 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92298 Chen J, Austin-Williams S, O'Riordan CE et al. (2023). Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction. nameOfConference DOI: 10.1159/000530284 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85560 Costa VV, Sugimoto MA, Hubner J et al. (publicationYear). Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease. nameOfConference DOI: 10.7554/elife.73853 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79205 Hamers A, Primus CP, Whitear C et al. (2022). 20‐hydroxyeicosatetraenoic acid (20‐HETE) is a pivotal endogenous ligand for TRPV1‐mediated neurogenic inflammation in the skin. nameOfConference DOI: 10.1111/bph.15726 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75763 Gee LC, Massimo G, Lau C et al. (2022). Inorganic nitrate attenuates cardiac dysfunction: roles for xanthine oxidoreductase and nitric oxide. nameOfConference DOI: 10.1111/bph.15636 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73324 Chen J, Norling LV, Mesa JG et al. (2021). Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis. nameOfConference DOI: 10.1073/pnas.2020385118 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74989 de Gaetano M, Tighe C, Gahan K et al. (2021). Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms). nameOfConference DOI: 10.1021/acs.jmedchem.1c00403 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74918 Kieswich JE, Chen J, Alliouachene S et al. (2020). Immunohistochemistry of Kidney a-SMA, Collagen 1, and Collagen 3, in A Novel Mouse Model of Reno-cardiac Syndrome.. nameOfConference DOI: 10.21769/bioprotoc.3751 QMRO: qmroHref Chen J, Purvis GSD, Collotta D et al. (2020). RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance. nameOfConference DOI: 10.3389/fimmu.2020.02080 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67161 Aziz Q, Chen J, Moyes AJ et al. (2020). Vascular KATP channels protect from cardiac dysfunction and preserve cardiac metabolism during endotoxemia. nameOfConference DOI: 10.1007/s00109-020-01946-3 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65764 Yun Y, Chen J, Liu R et al. (2019). Long residence time adenosine A1 receptor agonists produce sustained wash-resistant antilipolytic effect in rat adipocytes. nameOfConference DOI: 10.1016/j.bcp.2019.03.032 QMRO: qmroHref Al Zoubi S, Chen J, Murphy C et al. (publicationYear). Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB. nameOfConference DOI: 10.3389/fimmu.2018.02996 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55015 Kieswich JE, Chen J, Alliouachene S et al. (2018). A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain. nameOfConference DOI: 10.1186/s12882-018-1155-3 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60832 de Gaetano M, Butler E, Gahan K et al. (2019). Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms). nameOfConference DOI: 10.1016/j.ejmech.2018.10.049 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/52303 Chen J, Hamers AJP, Finsterbusch M et al. (2018). Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.. nameOfConference DOI: 10.1096/fj.201701303R QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/50363 Khan AI, Kapoor A, Chen J et al. (2018). The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction.. nameOfConference DOI: 10.1097/SHK.0000000000000963 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/43663 Purvis GSD, Chiazza F, Chen J et al. (2017). Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes. nameOfConference DOI: 10.1007/s00125-017-4469-y QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/28601 Johnson FL, Patel NSA, Purvis GSD et al. (2017). Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis.. nameOfConference DOI: 10.1161/JAHA.116.005092 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/24783 Martin L, Gombert A, Chen J et al. (2017). The β-d-Endoglucuronidase Heparanase Is a Danger Molecule That Drives Systemic Inflammation and Correlates with Clinical Course after Open and Endovascular Thoracoabdominal Aortic Aneurysm Repair: Lessons Learnt from Mice and Men.. nameOfConference DOI: 10.3389/fimmu.2017.00681 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/25296 Martin L, Chen J, Zechendorf E et al. (2017). ROLE OF THE beta-D-ENDOGLUCURONIDASE HEPARANASE IN SEPTIC CARDIOMYOPATHY. European Shock Society DOI: doi QMRO: qmroHref Chen J, Hamers AJP, Finsterbusch M et al. (2016). ACTIVATION OF TRPV1 BY 12(S)-HPETE AND 20-HETE RELEASES CGRP AND PROTECTS THE HEART AGAINST THE CARDIAC DYSFUNCTION CAUSED BY LPS. Exp Biology 2016 DOI: doi QMRO: qmroHref Martin LB, Zechendorf E, Chen J et al. (2016). THE SYNTHETIC ANTIMICROBIAL PEPTIDE 19-2.5 ATTENUATES SEPTIC CARDIOMYOPATHY IN A MURINE MODEL OF POLYMICROBIAL SEPSIS. Japanese Shock Society DOI: doi QMRO: qmroHref Chen J, Thiemermann C (2016). Selenium and Niacin for Sepsis Therapy. nameOfConference DOI: 10.1097/ccm.0000000000001493 QMRO: qmroHref Chen J, Kieswich J, Chiazza F et al. (publicationYear). IkB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD. nameOfConference DOI: 10.1681/ASN.2015060670 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/12841 Chen J, Hamers AJP, Finsterbusch M et al. (2016). Activation of TRPV1 by 12(s)-HpETE and 20-HETE Releases CGRP and Protects the Heart Against the Cardiac Dysfunction Caused by LPS. Exp Biology (FASEB) 2016 DOI: 10.1096/fasebj.30.1_supplement.306.4 QMRO: qmroHref Zhang W, Zhao X, Xiao Y et al. (2016). The association of depressed angiogenic factors with reduced capillary density in the Rhesus monkey model of myocardial ischemia. nameOfConference DOI: 10.1039/c5mt00332f QMRO: qmroHref Chen J, Kieswich J, Chiazza F et al. (2015). THE CARDIAC DYSFUNCTION CAUSED BY SEPSIS IN ANIMALS WITH CHRONIC KIDNEY DISEASE IS ATTENUATED BY INHIBITING IκB KINASE. nameOfConference DOI: doi QMRO: qmroHref Gobbetti T, Coldewey SM, Chen J et al. (2014). Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis. nameOfConference DOI: 10.1073/pnas.1410938111 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/6704 Chen J, Chiazza F, Collino M et al. (publicationYear). Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency. nameOfConference DOI: 10.1371/journal.pone.0100631 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/12540 Chen J, Chiazza F, Collino M et al. (2014). GENDER DIMORPHISM OF THE CARDIAC DYSFUNCTION IN SEPSIS. nameOfConference DOI: doi QMRO: qmroHref Chen J, Kieswich J, Yaqoob MM et al. (2014). PRE-EXISTING CHRONIC KIDNEY DISEASE WORSENS MYOCARDIAL DYSFUNCTION CAUSED BY SEPSIS IN MICE. nameOfConference DOI: doi QMRO: qmroHref Sun X, Cai J, Fan X et al. (publicationYear). Decreases in Electrocardiographic R-Wave Amplitude and QT Interval Predict Myocardial Ischemic Infarction in Rhesus Monkeys with Left Anterior Descending Artery Ligation. nameOfConference DOI: 10.1371/journal.pone.0071876 QMRO: qmroHref Hafner S, Wepler M, McCook O et al. (2013). EFFECTS OF THE PPAR-β/δ AGONIST GW0742 ON RENAL INFLAMMATION AND KIDNEY TISSUE INJURY DURING RESUSCITATED PORCINE SEPTIC SHOCK. nameOfConference DOI: doi QMRO: qmroHref Xie Y, Chen J, Han P et al. (2012). Immunohistochemical detection of differentially localized up-regulation of lysyl oxidase and down-regulation of matrix metalloproteinase-1 in rhesus monkey model of chronic myocardial infarction. nameOfConference DOI: 10.1258/ebm.2012.012070 QMRO: qmroHref Sponsors Versus Arthritis Heart Research UK British Heart Foundation Barts Charity British Pharmacology Society CollaboratorsInternal Prof Mauro Perretti (Sponsor of VA Fellowship, WHRI) Dr Dianne Cooper (Sponsor of VA Fellowship, WHRI) Dr Lucy Norling (WHRI) Prof Federica Marelli-Berg (WHRI) Dr Nay Aung (Digital Environment Research Institute (DERI) Dr Dunja Aksentijevic (WHRI) Dr Myles Lewis (WHRI) Prof Steffen Peterson (WHRI) Dr Trinidad Montero-Melendez (WHRI) Prof Christoph Thiemermann (WHRI) International Collaborators Dr Andreas Margraf (Ludwig-Maximilians University Munich) Industry Collaborators Dr John Lupisella (Bristol-Myers Squibb) Dr Ricardo Garcia (Bristol-Myers Squibb) Dr Thomas Jonassen (ResoTher Pharma) Dr Samra Sanni (ResoTher Pharma) Versus Arthritis Research Partner Mr Robin Brittain News PhD studentship grant awarded to Dr Jianmin Chen. How can we treat heart problems in patients with rheumatoid arthritis? (Heart Research UK), May 2023 Jianmin Chen, The female researchers of Heart Research UK (Heart Research UK), March 2023 New model could improve treatment of rheumatoid arthritis patients with cardiac disease (Queen Mary University of London), September 2021 Teaching MRes research project supervisor and lecturer: MRes Cardiac and Vascular Medicine - Inflammation: Cellular and Vascular Aspects (WHRM922) Bsc research project supervisor: BSc Pharmacology - Research Project in Pharmacology (BMD670) PBL tutor (MBBS) OSCE examiner (MBBS) DisclosuresNo disclosures. Back to top